IDNA
iShares Genomics Immunology and Healthcare ETFNYSE
Updated 1 day ago
Coverage limited
$40.79-1.85%
Close Oct 13, 2026
- Market cap
- —
- 1 month
- +5.3%
- 3 months
- +23.2%
- 1 year
- +69.8%
- 52-week range
- $24.24$42.72
- Dividend, last 12 mo
- $0.2809 · 0.69% yield
- Last ex-date
- Jun 15, 2026 · $0.1254
- Dividend growth
- 1 year in a row
- Short interest
- 218.6K sharessettled Sep 30, 2026 · +847.2% since Sep 15, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if IDNA is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: MEDIUM
10 top institutions tracked
as of 2026-Q2 (filed 2026-09-23)
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
Largest 13-F holders · Q2 2026
66 filers reported a long position in IDNA for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| UBS Group AG | $16.7M | 493.6K | +1.4% |
| BANK OF AMERICA CORP /DE/ | $15.8M | 467K | +1.8% |
| Wharton Business Group, LLC | $9.1M | 268.5K | -0.6% |
| JANE STREET GROUP, LLC | $3.9M | 114.9K | New |
| AMERIPRISE FINANCIAL INC | $3.7M | 111.1K | -2.9% |
| Portland Global Advisors LLC | $3.6M | 105.3K | +1.1% |
| WELLS FARGO & COMPANY/MN | $3.2M | 95.4K | +283.6% |
| Trek Financial, LLC | $3.1M | 90.9K | New |
| ROYAL BANK OF CANADA | $3M | 88.5K | +70.8% |
| MORGAN STANLEY | $2.7M | 81.3K | -13.7% |
Get the Full Analysis for IDNA
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.